PH15024A - Pharmaceutical compositions containing a xanthine derivatives and method of use - Google Patents
Pharmaceutical compositions containing a xanthine derivatives and method of useInfo
- Publication number
- PH15024A PH15024A PH22400A PH22400A PH15024A PH 15024 A PH15024 A PH 15024A PH 22400 A PH22400 A PH 22400A PH 22400 A PH22400 A PH 22400A PH 15024 A PH15024 A PH 15024A
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- xanthine derivatives
- xanthine
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1600878 | 1978-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH15024A true PH15024A (en) | 1982-05-13 |
Family
ID=10069529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH22400A PH15024A (en) | 1978-04-22 | 1979-04-19 | Pharmaceutical compositions containing a xanthine derivatives and method of use |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0005015B1 (de) |
JP (1) | JPS54143527A (de) |
AU (1) | AU523136B2 (de) |
CA (1) | CA1117419A (de) |
DE (1) | DE2967632D1 (de) |
DK (1) | DK164679A (de) |
FR (1) | FR2423222A1 (de) |
IL (1) | IL57711A0 (de) |
PH (1) | PH15024A (de) |
ZA (1) | ZA791911B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL59664A0 (en) * | 1979-04-05 | 1980-06-30 | Wuelfing J Kg | Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions |
DE3127237A1 (de) * | 1981-07-10 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung |
GB8418430D0 (en) * | 1984-07-19 | 1984-08-22 | Beecham Wuelfing Gmbh & Co Kg | Treatment |
GB8501488D0 (en) * | 1985-01-21 | 1985-02-20 | Beecham Group Plc | Treatment |
US5096906A (en) * | 1986-12-31 | 1992-03-17 | University Of Virginia Alumni Patents Foundation | Method of inhibiting the activity of leukocyte derived cytokines |
US4965271A (en) * | 1986-12-31 | 1990-10-23 | Hoechst Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
IL100535A (en) * | 1986-12-31 | 1994-05-30 | Hoechst Roussel Pharma | Pharmaceutical preparations containing a history of xanthine to relieve disease states |
US6420374B1 (en) | 1990-11-30 | 2002-07-16 | Fred Hutchinson Cancer Research Center | Use of xanthines as immunosuppressants and to inhibit allograft reactions |
EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
JP2584507Y2 (ja) * | 1993-05-24 | 1998-11-05 | 住友電装株式会社 | 電線の防水構造 |
HUP0400931A2 (hu) * | 1997-11-28 | 2004-07-28 | Karsanov, Nyikolai Vaszilievics | Hypoxia és ischaemia elleni gyógyszer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
DE2462367A1 (de) * | 1974-01-22 | 1976-11-11 | Wuelfing J A Fa | 7-(oxoalkyl)-1,3-dialkylxanthine enthaltende arzneimittelzubereitungen |
CH608236A5 (de) * | 1974-01-22 | 1978-12-29 | Wuelfing J A Fa |
-
1979
- 1979-03-29 EP EP79300516A patent/EP0005015B1/de not_active Expired
- 1979-03-29 DE DE7979300516T patent/DE2967632D1/de not_active Expired
- 1979-04-18 FR FR7909739A patent/FR2423222A1/fr active Granted
- 1979-04-19 PH PH22400A patent/PH15024A/en unknown
- 1979-04-19 CA CA000325879A patent/CA1117419A/en not_active Expired
- 1979-04-20 AU AU46222/79A patent/AU523136B2/en not_active Ceased
- 1979-04-20 DK DK164679A patent/DK164679A/da not_active IP Right Cessation
- 1979-04-23 JP JP5023279A patent/JPS54143527A/ja active Granted
- 1979-04-23 ZA ZA791911A patent/ZA791911B/xx unknown
- 1979-07-02 IL IL57711A patent/IL57711A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK164679A (da) | 1979-12-03 |
AU523136B2 (en) | 1982-07-15 |
IL57711A0 (en) | 1979-11-30 |
CA1117419A (en) | 1982-02-02 |
EP0005015B1 (de) | 1986-10-29 |
ZA791911B (en) | 1980-04-30 |
JPH02326B2 (de) | 1990-01-08 |
JPS54143527A (en) | 1979-11-08 |
EP0005015A1 (de) | 1979-10-31 |
FR2423222B1 (de) | 1982-07-16 |
FR2423222A1 (fr) | 1979-11-16 |
AU4622279A (en) | 1979-11-22 |
DE2967632D1 (en) | 1986-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL57450A0 (en) | Aminothiazole derivatives and pharmaceutical compositions containing them | |
DE2962923D1 (en) | Preparation of n-substituted derivatives of 1-deoxy-nojirimycine | |
IL61936A (en) | Derivatives of cba2 and pharmaceutical compositions containing them | |
IL56407A (en) | 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them | |
NZ189721A (en) | Propanone derivatives and pharmaceutical compositions | |
PT69821A (en) | Process for the preparation of new 5-phenylpyrazole derivatives the salts thereof and the pharmaceutical compositions containing same | |
IL57040A0 (en) | Mercaptoimidazole derivatives their preparation and pharmaceutical compositions containing them | |
IL56821A0 (en) | Heterocycylcarbonyl derivatives of ure and pharmaceutical composition containing them | |
PH15024A (en) | Pharmaceutical compositions containing a xanthine derivatives and method of use | |
ZA793769B (en) | Pharmaceutical formulation of guar gum | |
IL57268A0 (en) | Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them | |
GB2039736B (en) | Pharmaceutical compositions containing thiazolidine-4-carboxylic acid and method of preparation | |
NZ191169A (en) | N-substituted aziridine-2-carboxylic acid derivatives and pharmaceutical compositions | |
NZ192142A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
IL58620A0 (en) | Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them | |
IL58125A0 (en) | N-phenylindoline derivatives their production and pharmaceutical compositions containing | |
NZ190245A (en) | Isoquinoline derivatives and pharmaceutical compositions containing them | |
DE2861607D1 (en) | Derivatives of clavulanic acid and pharmaceutical compositions containing them | |
IL57436A0 (en) | Hydantoin derivatives and pharmaceutical compositions containing them | |
IL57488A (en) | L-cysteine derivatives and pharmaceutical compositions containing them | |
NZ190007A (en) | Steroid-spiro-oxazolidinone derivatives and pharmaceutical compositions | |
GB2013671B (en) | Azathianaphthalene derivatives process for their manufactue pharmaceutical preparations containing them and their use | |
PH18155A (en) | Ergot peptide alkaloid derivatives and pharmaceutical compositions containing them | |
GB2017096B (en) | 8-hydrazinomethylergoline derivatives and pharmaceutical compositions containing them | |
ZA794940B (en) | Imidazolylethoxy derivatives of pyridin-5-methanols and quinoline-3-methanols |